Fact CheckerSign in

NCT07203937Not yet recruiting

Effects of Robotic Rehabilitation on Quality of Life, Mood, and Fatigue After Stroke

Effects of Combined Robotic and Conventional Lower Limb Rehabilitation on Quality of Life, Depression, Anxiety, and Fatigue After Stroke: A Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 26 Jan 2026

Brief summary (registry, in English)

Stroke is a major cause of long-term disability and is often associated with reduced quality of life, depression, anxiety, and fatigue. Rehabilitation plays a key role in recovery, and robotic-assisted gait training provides intensive, repetitive, and individualized therapy. However, its effects on psychological outcomes and quality of life are not fully established. This randomized controlled trial will compare conventional rehabilitation combined with robotic-assisted gait training to conventional rehabilitation combined with treadmill training in stroke survivors. Both groups will receive treatment 5 days per week for 6 weeks. Assessments will be conducted at baseline, after 6 weeks of treatment, and at 3 months after treatment. The primary outcome is quality of life. Secondary outcomes include depression, anxiety, and fatigue. The results of this study will provide new evidence on the benefits of robotic rehabilitation for improving both physical and psychological well-being after stroke.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
36 (estimated)
First submitted
24 Sept 2025
Start date
15 Jan 2026
Primary completion date
Jul 2026
Lead sponsor
Meltem Gunes Akinci
Diseases
Stroke
NCT number
NCT07203937

What you commit to

  • Study type: Interventional
  • Planned participants: 36
  • From 15 Jan 2026 to the primary completion date, Jul 2026
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Severe cognitive or communication impairment
  • Uncontrolled hypertension or orthostatic hypotension
  • Severe cardiovascular disease, heart failure, cancer, or significant pulmonary disease
  • Ambulation difficulty caused by lower extremity musculoskeletal disorders

Other

  • Mobility limitations due to joint contracture or deformity
  • Presence of open wounds or pressure ulcers
  • High fracture risk due to severe osteoporosis
  • Severe psychosis or neurosis
  • Modified Ashworth Scale score \> 3 in the lower extremities

Who the study is looking for

  • Age between 18 and 75 years
  • History of ischemic or hemorrhagic stroke at least 3 months prior to enrollment
  • Mini Mental State Examination (MMSE) score of 24 or higher
  • Modified Ashworth Scale score \< 2 in the lower extremities

Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.